Braxia Scientific CEO to Deliver Keynote Address at H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond
- Friday, June 24, 2022, 7:04
- Finance
- Add a comment
TORONTO, June 24, 2022 /PRNewswire/ – Braxia Scientific Corp. (“Braxia”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company with clinics providing innovative ketamine treatments for persons with depression and related disorders, is pleased to announce its…
About the Author
adminasapcorp has written 41555 stories on this site.